Eric Boutin

Eric Boutin is an accomplished serial entrepreneur and Managing Director at dRx Capital, Novartis’ digital health venture capital fund. He previously served as Founder and CEO of Evolve, a mobile technology and machine learning company, which was acquired by HubSpot. Prior to that, he was Founder and CEO of Good Start Genetics, a molecular diagnostics company, which was acquired by Invitae. Eric was also Founder of Flex Pharma, a biopharmaceutical company dedicated to creating novel treatments for neuromuscular disorders, which went public in 2015. Eric was an Investor at Longwood Fund, and is currently a member of NextGen Venture Partners. He holds a BA from Duke University, and an MBA from Harvard Business School.